{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:21Z","timestamp":1791407361684,"version":"4.3.3"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The recent discovery that sporadic and familial primary pulmonary hypertension can be associated with germline mutations of genes encoding receptor members of the transforming growth factor-beta family has focused much attention on cytokines and growth factors in pulmonary vascular disorders. Production of several cytokines has been demonstrated in severe pulmonary arterial hypertension, emphasizing the possible influence of inflammatory mechanisms in this condition. Moreover, perivascular inflammatory cell infiltrates composed of macrophages and lymphocytes have been detected in plexiform lesions of primary pulmonary hypertension. Chemokine RANTES is an important chemoattractant for monocytes and T cells. We therefore hypothesize that chemokine RANTES promotes cell recruitment in the lungs of patients displaying severe pulmonary arterial hypertension. Reverse transcriptase polymerase chain reaction demonstrated elevated RANTES mRNA expression in 10 lung samples from patients with severe pulmonary arterial hypertension, as compared with seven control subjects. In situ hybridization and immunohistochemistry confirmed that endothelial cells were the major source of RANTES within the pulmonary artery wall of the patients. Serial sections analysis showed that RANTES expression was associated with CD45 + inflammatory cell infiltrates. These results support the concept that inflammatory mechanisms play a role in the natural history of pulmonary arterial hypertension.<\/jats:p>","DOI":"10.1164\/ajrccm.165.4.2012112","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:57:41Z","timestamp":1365087461000},"page":"534-539","source":"Crossref","is-referenced-by-count":239,"title":["Chemokine RANTES in Severe Pulmonary Arterial Hypertension"],"prefix":"10.1093","volume":"165","author":[{"given":"Peter","family":"Dorfm\u00fcller","sequence":"first","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Zarka","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Durand-Gasselin","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaola","family":"Monti","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Balabanian","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Garcia","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Capron","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Coulomb-Lhermin\u00e9","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Marfaing-Koka","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Simonneau","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Emilie","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Humbert","sequence":"additional","affiliation":[{"name":"Center for Pulmonary Vascular Diseases, UPRES EA 2705; Department of Respiratory and Intensive Care Medicine, INSERM U131; Department of Pathology; and Department of Hematology, South-Paris Cytokine Institute, Antoine B\u00e9cl\u00e8re Hospital, Assistance Publique H\u00f4pitaux de Paris, South-Paris University, Clamart, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2002,2,15]]},"reference":[{"key":"2026031623142521500_B1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM199701093360207","article-title":"Primary pulmonary hypertension.","volume":"336","author":"Rubin","year":"1997","journal-title":"N Engl J Med"},{"key":"2026031623142521500_B2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0272-5231(05)70284-7","article-title":"Risk factors for pulmonary arterial hypertension.","volume":"22","author":"Humbert","year":"2001","journal-title":"Clin Chest Med"},{"key":"2026031623142521500_B3"},{"key":"2026031623142521500_B4","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.","volume":"67","author":"Deng","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2026031623142521500_B5","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-\u03b2 family.","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"key":"2026031623142521500_B6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1086\/316947","article-title":"BMPR2 haploinsufficiency as the inherited mechanism for primary pulmonary hypertension.","volume":"68","author":"Machado","year":"2001","journal-title":"Am J Hum Genet"},{"key":"2026031623142521500_B7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.","volume":"345","author":"Trembath","year":"2001","journal-title":"N Engl J Med"},{"key":"2026031623142521500_B8","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1161\/01.RES.88.1.e2","article-title":"Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension.","volume":"88","author":"Yeager","year":"2001","journal-title":"Circ Res"},{"key":"2026031623142521500_B9","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1164\/ajrccm.151.5.7735624","article-title":"Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension.","volume":"151","author":"Humbert","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623142521500_B10","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1183\/09031936.98.11030554","article-title":"Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients.","volume":"11","author":"Humbert","year":"1998","journal-title":"Eur Respir J"},{"key":"2026031623142521500_B11","first-page":"275","article-title":"Exuberant endothelial cell growth and element of inflammation are present in plexiform lesions of pulmonary hypertension.","volume":"144","author":"Tuder","year":"1994","journal-title":"Am J Pathol"},{"key":"2026031623142521500_B12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","article-title":"Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm.","volume":"76","author":"Springer","year":"1994","journal-title":"Cell"},{"key":"2026031623142521500_B13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines\u2014chemotactic cytokines that mediate inflammation.","volume":"338","author":"Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"2026031623142521500_B14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/347669a0","article-title":"Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.","volume":"347","author":"Schall","year":"1998","journal-title":"Nature"},{"key":"2026031623142521500_B15","first-page":"257","article-title":"Quantification of cytokine gene expression by competitive PCR using a colorimetric assay.","volume":"6","author":"Zou","year":"1995","journal-title":"Eur Cytokine Netw"},{"key":"2026031623142521500_B16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1172\/JCI114678","article-title":"Production of interleukins in human immunodeficiency virus-1 replicating lymph nodes.","volume":"86","author":"Emilie","year":"1990","journal-title":"J Clin Invest"},{"key":"2026031623142521500_B17","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/01.CIR.80.5.1198","article-title":"Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung and Blood Institute, primary pulmonary hypertension registry.","volume":"80","author":"Pietra","year":"1989","journal-title":"Circulation"},{"key":"2026031623142521500_B18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension.","volume":"99","author":"Herv\u00e9","year":"1995","journal-title":"Am J Med"},{"key":"2026031623142521500_B19","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.ATV.20.10.2233","article-title":"High plasma serotonin levels in primary pulmonary hypertension: effect of long-term epoprostenol (prostacyclin) therapy.","volume":"20","author":"Kereveur","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026031623142521500_B20","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension.","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"key":"2026031623142521500_B21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM199207093270209","article-title":"Endothelial dysfunction in pulmonary hypertension.","volume":"327","author":"Loscalzo","year":"1992","journal-title":"N Engl J Med"},{"key":"2026031623142521500_B22","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"2026031623142521500_B23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.","volume":"333","author":"Giaid","year":"1995","journal-title":"N Engl J Med"},{"key":"2026031623142521500_B24"},{"key":"2026031623142521500_B25","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension.","volume":"159","author":"Tuder","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623142521500_B26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1378\/chest.114.5.1276","article-title":"Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension.","volume":"114","author":"Lopes","year":"1998","journal-title":"Chest"},{"key":"2026031623142521500_B27","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0002-8703(00)90038-3","article-title":"Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension.","volume":"139","author":"Lopes","year":"2000","journal-title":"Am Heart J"},{"key":"2026031623142521500_B28","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1161\/01.CIR.102.20.2460","article-title":"Improvement of von Willebrand factor proteolysis after prostacyclin infusion in severe pulmonary arterial hypertension.","volume":"102","author":"Veyradier","year":"2000","journal-title":"Circulation"},{"key":"2026031623142521500_B29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.CIR.70.4.580","article-title":"Primary pulmonary hypertension: natural history and the importance of thrombosis.","volume":"70","author":"Fuster","year":"1984","journal-title":"Circulation"},{"key":"2026031623142521500_B30","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1172\/JCI1910","article-title":"Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension.","volume":"101","author":"Lee","year":"1998","journal-title":"J Clin Invest"},{"key":"2026031623142521500_B31","first-page":"A143","article-title":"Endothelium dysfunction in severe pulmonary arterial hypertension: elevated plasma and pulmonary vascular adhesion molecules.","volume":"161","author":"Belliard","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"2026031623142521500_B32","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1378\/chest.114.1_Supplement.50S","article-title":"Chemokine MIP-1\u03b1 expression in lung biopsies of primary pulmonary hypertension.","volume":"114","author":"Fartoukh","year":"1998","journal-title":"Chest"},{"key":"2026031623142521500_B33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1523-1755.1998.00053.x","article-title":"In situ analysis of C-C chemokine mRNA in human glomerulonephritis.","volume":"54","author":"Cockwell","year":"1998","journal-title":"Kidney Int"},{"key":"2026031623142521500_B34","first-page":"1179","article-title":"Evidence for RANTES, monocyte chemotactic protein-1, and macrophage inflammatory protein-1 beta expression in Kawasaki disease.","volume":"24","author":"Wong","year":"1997","journal-title":"J Rheumatol"},{"key":"2026031623142521500_B35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/01.CIR.100.1.55","article-title":"Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?","volume":"100","author":"Noris","year":"1999","journal-title":"Circulation"},{"key":"2026031623142521500_B36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1084\/jem.188.1.193","article-title":"In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II.","volume":"188","author":"Chen","year":"1998","journal-title":"J Exp Med"},{"key":"2026031623142521500_B37","doi-asserted-by":"crossref","first-page":"19000","DOI":"10.1074\/jbc.M001222200","article-title":"Identification and characterization of a potent, selective and orally active antagonist of the CC chemokine receptor-1.","volume":"275","author":"Liang","year":"2000","journal-title":"J Biol Chem"},{"key":"2026031623142521500_B38","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1096\/fasebj.13.11.1371","article-title":"1Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.","volume":"13","author":"Grone","year":"1999","journal-title":"FASEB J"},{"key":"2026031623142521500_B39","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-6749(00)90084-8","article-title":"Chemokine- and cytokine-induced expression of endothelin 1 and endothelin-converting enzyme 1 in endothelial cells.","volume":"105","author":"Molet","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"2026031623142521500_B40","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.CIR.102.4.411","article-title":"Hemodynamic effects of Bosentan, an endothelin receptor antagonist, in patients with primary pulmonary hypertension.","volume":"102","author":"Williamson","year":"2000","journal-title":"Circulation"},{"key":"2026031623142521500_B41","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"2026031623142521500_B42","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.4049\/jimmunol.164.5.2285","article-title":"TGF-\u03b2 1 reciprocally controls chemotaxis of human peripheral blood monocyte derived dendritic cells via chemokine receptors.","volume":"164","author":"Sato","year":"2000","journal-title":"J Immunol"},{"key":"2026031623142521500_B43","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.4049\/jimmunol.154.4.1870","article-title":"Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by interferon-\u03b3 plus TNF\u03b1 and inhibition by IL-4 and IL-13.","volume":"154","author":"Marfaing-Koka","year":"1995","journal-title":"J Immunol"},{"key":"2026031623142521500_B44"},{"key":"2026031623142521500_B45","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/intimm\/8.10.1587","article-title":"Contrasting effects of interleukin-4, interleukin-10 and corticosteroids on RANTES production by human monocytes.","volume":"8","author":"Marfaing-Koka","year":"1996","journal-title":"Int Immunol"},{"key":"2026031623142521500_B46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1161\/01.RES.88.6.555","article-title":"Gene expression patterns in the lungs of patients with primary pulmonary hypertension: a gene microarray analysis.","volume":"88","author":"Geraci","year":"2001","journal-title":"Circ Res"},{"key":"2026031623142521500_B47","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1165\/ajrcmb.11.6.7946395","article-title":"Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.","volume":"11","author":"Voelkel","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026031623142521500_B48","first-page":"571","article-title":"Alleviation of monocrotaline-induced pulmonary hypertension by antibodies to monocyte chemotactic and activating factor\/monocyte chemoattractant protein-1.","volume":"78","author":"Kimura","year":"1998","journal-title":"Lab Invest"},{"key":"2026031623142521500_B49","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1183\/09031936.95.08122129","article-title":"Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension.","volume":"8","author":"Voelkel","year":"1995","journal-title":"Eur Respir J"},{"key":"2026031623142521500_B50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.55.8.561","article-title":"Improvement of severe pulmonary hypertension in a patient with SLE.","volume":"55","author":"Karmochkine","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"2026031623142521500_B51","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/thx.54.3.273","article-title":"Treatment of pulmonary hypertension secondary to connective tissue diseases.","volume":"54","author":"Sanchez","year":"1999","journal-title":"Thorax"},{"key":"2026031623142521500_B52","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/thx.54.4.372","article-title":"Effective immunosuppressive therapy in a patient with primary pulmonary hypertension.","volume":"54","author":"Belloto","year":"1999","journal-title":"Thorax"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/165\/4\/534\/67366812\/ajrccm_165_4_534.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/165\/4\/534\/67366812\/ajrccm_165_4_534.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:19:56Z","timestamp":1773717596000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/165\/4\/534\/8517233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2002,2,15]]},"published-print":{"date-parts":[[2002,2,15]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.165.4.2012112","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2002,2]]},"published":{"date-parts":[[2002,2]]}}}